Atara Biotherapeutics Inc
USPTO Trademark & Patent Filings
Trademark applications and grants for Atara Biotherapeutics Inc. Atara Biotherapeutics Inc has 42 trademark applications. The latest application filed is for "ATARA BIO"
- Company Aliases
- Atara Biotherapeutics, Inc.
- Atara Biotherapeutics, Inc. - South San Francisco CA US
Trademarks Patents
| Patent Application | Date |
|---|---|
| METHODS OF MANAGING TUMOR FLARE IN ADOPTIVE IMMUNOTHERAPY 20210393683 - 16/755745 Baiocchi; Robert | 2021-12-23 |
| METHODS FOR EXPANDING ANTIGEN-SPECIFIC CAR-T CELLS, COMPOSITIONS AND USES RELATED THERETO 20210301255 - 17/274673 Aftab; Blake T. ; et al. | 2021-09-30 |
| SYSTEMS AND METHODS FOR DISTRIBUTING CELL THERAPIES 20200350049 - 16/960767 Porter; Derrell D. | 2020-11-05 |
| METHODS OF TREATING MULTIPLE SCLEROSIS USING AUTOLOGOUS T CELLS 20190350981 - 16/479003 Khanna; Rajiv ; et al. | 2019-11-21 |
| NCAGE Code | 8APS1 | ATARA BIOTHERAPEUTICS, INC.!DBA ATARA BIO |
| CAGE Code | 8APS1 | ATARA BIOTHERAPEUTICS, INC. ATARA BIO |
| S.A.M. Registration | 8APS1 [61214697] | ATARA BIOTHERAPEUTICS, INC. ATARA BIO |
| SEC | 0001604464 | Atara Biotherapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 